Discontinuation report MYCOPHENOLATE MOFETIL FOR INJECTION USP

Last updated on 2024-02-06 History
Report ID 216963
Drug Identification Number 02479974
Brand name MYCOPHENOLATE MOFETIL FOR INJECTION USP
Common or Proper name MYCOPHENOLATE MOFETIL FOR INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) MYCOPHENOLATE MOFETIL
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 4 VIALS
ATC code L04AA
ATC description IMMUNOSUPPRESSANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2024-02-01
Actual discontinuation date
Remaining supply date 2024-02-01
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply Product will no longer be available upon the depletion of the limited inventory at McKesson.
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2024-02-06 French Compare
v3 2024-02-06 English Compare
v2 2024-01-22 French Compare
v1 2024-01-22 English Compare

Showing 1 to 4 of 4